Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma

Breast Cancer Research

Volumn 14, Issue 1, 2012, Pages

  Serrero, Ginette ^a,c   Hawkins, Douglas M ^b   Yue, Binbin ^a   Ioffe, Olga ^c   Bejarano, Pablo ^d   Phillips, Jeffrey T ^e   Head, Jonathan F ^e   Elliott, Robert L ^e   Tkaczuk, Katherine R ^c   Godwin, Andrew K ^f   Weaver, JoEllen ^g   Kim, Wes E ^a  

^a A&G Pharmaceutical   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d JACKSON MEMORIAL HOSPITAL   (United States)

^e EEH Breast Cancer Research and Treatment Center   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^g FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROGRANULIN; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; ETHNICITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE RISK; RETROSPECTIVE STUDY; TUMOR VOLUME; VALIDATION STUDY; BREAST TUMOR; FEMALE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES;

EID: 84856618083     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3111     Document Type: Article

References (33)

1. He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl.) 2003, 81:600-612. 10.1007/s00109-003-0474-3, 12928786.
2. Serrero G. Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun 2003, 308:409-413. 10.1016/S0006-291X(03)01452-9, 12914763.
3. Tolkatchev D, Malik S, Vinogradova A, Wang P, Chen Z, Xu P, Bennett HP, Bateman A, Ni F. Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities. Protein Sci 2008, 17:711-724. 10.1110/ps.073295308, 2271164, 18359860.
4. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 2000, 60:4161-4166.
5. Egland KA, Vincent JJ, Strausberg R, Lee B, Pastan I. Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins. Proc Nat Acad Sci USA 2003, 100:1099-1104. 10.1073/pnas.0337425100, 298733, 12538848.
6. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, Ding A. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002, 111:867-878. 10.1016/S0092-8674(02)01141-8, 12526812.
7. He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med 2003, 9:225-229. 10.1038/nm816, 12524533.
8. Ong CH, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol 2003, 18:1275-1288.
9. Tangkeangsirisin W, Serrero G. PC-cell derived growth factor (PCDGF/GP88) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 2004, 25:1587-1589. 10.1093/carcin/bgh171, 15117809.
10. Halper J. Growth factors as active participants in carcinogenesis: a perspective. Vet Pathol 2010, 47:77-97. 10.1177/0300985809352981, 20080487.
11. Pizarro GO, Zhou XC, Koch A, Gharib M, Raval S, Bible K, Jones MB. Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse. Int J Cancer 2007, 120:2339-2343. 10.1002/ijc.22559, 17266030.
12. Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirström K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 2011, 121:784-799. 10.1172/JCI43757, 3026724, 21266779.
13. Zanocco-Marani T, Bateman A, Romano G, Valentini B, He ZH, Baserga R. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res 1999, 59:5331-5340.
14. Liu Y, Xi L, Liao G, Wang W, Tian X, Wang B, Chen G, Han Z, Wu M, Wang S, Zhou J, Xu G, Lu Y, Ma D. Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2. BMC Cancer 2007, 7:22. 10.1186/1471-2407-7-22, 1794415, 17261172.
15. Xu SQ, Tang D, Chamberlain S, Pronk G, Masiarz FR, Kaur S, Prisco M, Zanocco-Marani T, Baserga R. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem 1998, 273:20078-20083. 10.1074/jbc.273.32.20078, 9685348.
16. Lu R, Serrero G. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc Natl Acad Sci USA 2000, 97:3993-3998. 10.1073/pnas.97.8.3993, 18130, 10760271.
17. Lu R, Serrero G. Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells. Biochem Biophys Res Commun 1999, 256:204-207. 10.1006/bbrc.1999.0253, 10066447.
18. Lu R, Serrero G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proc Natl Acad Sci USA 2001, 98:142-147. 10.1073/pnas.011525198, 14558, 11134521.
19. Tangkeangsirisin W, Hayashi J, Serrero G. PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Res 2004, 64:1737-1743. 10.1158/0008-5472.CAN-03-2364, 14996734.
20. Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. BMC Cancer 2011, 11:231. 10.1186/1471-2407-11-231, 3129588, 21658239.
21. Kim WE, Serrero G. PC-cell derived growth factor stimulates proliferation and confers Trastuzumab resistance to Her-2-overexpressing breast cancer cells. Clin Cancer Res 2006, 12:4192-4199. 10.1158/1078-0432.CCR-05-2663, 16857791.
22. Serrero G, Ioffe O. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Hum Pathol 2003, 34:1148-1154. 10.1016/S0046-8177(03)00425-8, 14652816.
23. Song H, Shi L, Liu C, Huang T. Expression of PC-cell-derived growth factor in breast cancer. Front Med China 2009, 3:426-430.
24. Glass AG, Donis-Keller H, Mies C, Russo J, Zehnbauer B, Taube S, Aamodt R, . for the Cooperative Breast Cancer Tissue Resource The Cooperative Breast Cancer Tissue Resource: archival tissue for the investigation of tumor markers. Clin Cancer Res 2001, 7:1843-1849. for the Cooperative Breast Cancer Tissue Resource.
25. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005, 97:1180-1184. 10.1093/jnci/dji237, 16106022.
26. Davidson B, Alejandro E, Florenes VA, Goderstad J-M, Risberg B, Kristensen GB, Trope CG, Kohn EC. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer 2004, 100:2139-2147. 10.1002/cncr.20219, 15139056.
27. Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Rel Cancer 2010, 17:R245-262.
28. Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki67 in early breast cancer. J Clin Oncol 2005, 23:7212-7220. 10.1200/JCO.2005.07.501, 16192605.
29. Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, A'Hern R, Salter J, Detre S, Hills M, Walsh G. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst 2007, 99:167-170. 10.1093/jnci/djk020, 17228000.
30. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerman DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated node negative breast cancer. New Engl J Med 2004, 351:2817-2826. 10.1056/NEJMoa041588, 15591335.
31. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton M, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536. 10.1038/415530a, 11823860.
32. Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, Osborne CK, Allred DC, Erlander MG. The HoxB13:Il17BR expression index is a prognostic factor in early breast cancer. J Clin Oncol 2006, 24:4611-4618. 10.1200/JCO.2006.06.6944, 17008703.
33. Tkaczuk KR, Yue B, Zhan M, Tait N, Yarlagadda L, Dai H, Serrero G. Increased circulating level of the survival factor GP88 (progranulin) in the serum of breast cancer patients when compared to healthy subjects. Breast Cancer (Auckl) 2011, 5:155-162. 3140268, 21792312.